Nasal administration of ondansetron using a novel microspheres delivery system Part II: Ex vivo and in vivo studies

Pharmaceutical Development and Technology

Volumn 15, Issue 6, 2010, Pages 653-657

  Mahajan, Hitendra S ^a   Gattani, Surendra G ^a  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Bioavailability; Gellan gum; Microspheres; Mucoadhesive; Nasal

Indexed keywords

GELLAN; MICROSPHERE; ONDANSETRON;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; IN VIVO STUDY; MAXIMUM PLASMA CONCENTRATION; MUCOADHESION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ADHESIVENESS; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; INJECTIONS, INTRAVENOUS; MICROSPHERES; ONDANSETRON; POLYSACCHARIDES, BACTERIAL; RABBITS; SEROTONIN ANTAGONISTS;

EID: 78149240648     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450903479970     Document Type: Article

References (14)

1. Mahajan HS, Gattani SG. Nasal administration of ondansetron using a novel microspheres delivery system. Pharmaceut Develop Technol 2009;14(2):226-232.
2. Nagai T, Machida Y. Advances in drug delivery: Mucosal adhesive dosage forms. Pharm Int 1985;6:196-200.
3. Illum L. Chitosan and its use as pharmaceutical excipients. Pharm Res 1998;15:1326-1331.
4. Cetin Tas, Cansel O, Ayhan Savaser, Yalcin Ozkan. Nasal administration of metoclopramide from different dosage forms: In vitro, ex vivo and in vivo evaluation. Drug Deliv 2009;16(3):167-175.
5. Murthy R.S.R. Majithiya R.J. Ghosh P.K. Thermoreversiblemucoadhesive gel for nasal delivery of sumatriptan AAPS Pharm .Sci. Tech. 2006 7 3 E1-E7
6. Doneti P, Zia H, Needham TE. In vivo evaluation of spray formulation of human insulin for nasal delivery. Int J Pharm 1995;122:91-105.
7. Eunsook C, Hyesun G, Inkoo C. Formulation and evaluation of ondansetron nasal delivery systems. Int J Pharm 2008;349:101-107.
8. Tuker S, Onur E, Ozer Y. Nasal route and drug delivery system. Pharm World Sci 2004;26:137-142.
9. Quaraishi MS, Jones NS, Mason JD. The nasal delivery of drugs. Clin Otolaryngol 1997;22:289-301.
10. Behl CR, Pimplaskar HK, Sileno J, Romeo VD. Effects of physicochemical properties and other factors on systemic nasal drug delivery. Adv Drug Deliv Rev 1998;29:89-116.
11. Pereswetoff-Morath L. Microspheres as nasal drug delivery systems. Adv Drug Deliv Rev 1998;29:185-194.
12. Ugwoke MI, Verbeke N, Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol 2001;53:3-22.
13. Alpar HO, Somavarapuo S, Atuah KN, Bramwell VW. Biodegradable mucoadhesive particulate for nasal and pulmonary antigen and DNA delivery. Adv Drug Deliv Rev 2005;57:411-430.
14. Illum L, Fisher AN, Jabbal Gill I, Davis SS. Bioadhesive starch microspheres and absorption enhancing agents acts synergistically to enhance nasal absorption of polypeptides. Int J Pharm 2001;222:109-119.